Recently, it has been reported that primary human keratinocytes express ET-A receptors and produce ET-1, which exert important functions at the skin level, such as increase of keratinocyte proliferation, neo-angiogenesis and leukocyte chemstimulates growth responses, demonstrating that endogenous ET-1 is one of the most important autocrine growth factors otaxis, which are among the main characteristics of psoriasis. To assess a possible ET-1 involvement in plaque-type psoriasis, for keratinocytes (7). Moreover, ET-1 could be involved in inflammatory mechanisms, as shown by their ability to stimu-ET-1 determinations were carried out in 15 sera and 8 lesional and non-lesional biopsy skin extracts from psoriatic patients and late neutrophil chemotaxis (8).
and Severity Index (PASI ). In our patients the median PASI score parametric tests were used: the Wilcoxon rank test, the Mann-Whitney test and, finally, the Spearman's rank correlation test. was 12.4, ranging from 6.3 to 31.7.
None of the patients had received topical or systemic antipsoriatic treatments for at least 10 days before enrollment. Cyclosporin A had RESULTS not been used in these patients during the previous cycle of therapy, excluding a possible induction of ET synthesis by this drug (15) .
ET-1 in sera
Other concomitant diseases were excluded by means of a complete clinical and laboratory examination. After blood collection, sera were
To compare serum ET-1 levels of psoriatic and normal subjects, stored at −80°C until used. 15 serum samples from the patients and 15 from the controls In 8 (4 males and 4 females; median age: 48 years 34-70; median were assayed using ELISA techniques. The serum median ET-PASI score: 14.5, range 6.3-31.7) of the 15 patients, 6-mm diagnostic
ET-1 in skin extracts
5 of the 15 controls, 6-mm punch biopsies were also performed at the volar surface of the forearm for the skin extraction procedures.
Other experiments were undertaken to investigate whether the For ET-1 and IL-8 determinations two commercially available difference observed at the systemic level could also be revealed ELISA kits (purchased from R&D: Human IL-8 and Human Endothelin-1 immunoassays; R&D Systems, Inc., Minneapolis, USA) were used according to the manufacturer's instruction.
For serum ET-1 measurements, 0.75 ml of an extraction solution including acetone:1 M HCl:water (405155) were added to 0.5 ml of the samples, and the mixture was then centrifuged for 20 min at 3,000 rpm in a refrigerated centrifuge, at 4°C. Supernatants were decanted into polypropylene tubes and dried in a centrifugal evaporator (Speedvac) for 5 h at 37°C. The pellets were reconstituted with 0.125 ml of sample diluent immediately before ET-1 measurements.
The sample total protein ( TP) content was measured using the Coomassie Protein Assay Reagent (Pierce Chemical, Rockford, USA) according to the manufacturer's recommendations.
For RT-PCR analysis, total RNA was extracted and purified from 3-mm punch biopsies by a commercial kit: RNAzol (Biotech Lab. Inc., Houston, Texas), using the guanidinium thiocyanate method (17). Two control subjects and three psoriatic patients were arbitrarily selected without knowing their serum and skin ET-1 levels. Due to the presence of degraded mRNA, the results of only one control and 2 patients are presented.
One microgram of RNA was reversely transcribed to cDNA and amplified by the RNA PCR kit (Perkin Elmer Co., Norwalk, CT ), according to the manufacturer's instructions, with specific primers for the ET-1 mRNA; the upstream primer, (5∞-TGCTCCT GCTCGTCCCTGATGGATAAAGAG-3∞) and the downstream primer, (5∞-GGTCACATAACGCTCTCTGGAGGGCTT-3∞) as reported by Pekonen et al. (18) . Briefly, reverse transcription was carried out at 42°C for 15 min in presence of downstream primers. The reaction was stopped by incubation at 99°C for 5 min and chilled in ice. The cDNA was amplified with 2.5 U Amplitaq (Roche, USA) for 30 cycles in presence of up-and downstream primers for ET-1. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH ) primers were included as an internal control. In all experiments, two control reactions, one containing no mRNA and the other containing no reverse transcriptase, were included. The amplified products were analyzed in a 2% Nu-Sieve agarose gel. Quantification of amplified products was achieved by scanning densitometry of the bands in ethidium bromide-stained gel and expressed as relative levels of specific mRNAs normalized to those of GAPDH. Fig. 1 . Correlations between the PASI scores and (A) the serum ETStatistical analysis 1 levels of 15 psoriatic patients (r=0.60, p<0.02); (B) the lesional skin ET-1 levels of 8 psoriatic patients (r=0.79, p<0.03). TP= Due to the unknown data distribution types, the results were expressed as median, minimum and maximum. Accordingly, the following nontotal protein. at the local level, comparing 8 lesional and 8 non-lesional skin extracts with 5 extracts from controls. The analysis of the results showed a significant increase of ET-1 levels in lesional psoriatic skin (median 27.0 pg/mg TP, minimum 6.3 pg/mg TP; maximum 60.0 pg/mg TP) as compared with either non-lesional skin (median 14.5 pg/mg TP; minimum under detection limit; maximum 28.0 pg/mg TP; p= 0.01) or normal skin (median 5.7 pg/mg TP, minimum under detection limit; maximum 23 pg/mg TP; p=0.04). No statistic- (Fig. 2) . A.U.= arbitrary units.
As previously reported for serum ET-1 amounts, a correlation between lesional skin extract ET-1 levels and PASI scores was also noted (r=0.80; p=0.03) (Fig. 1B) .
These results correlated perfectly with those from ELISA experiments, confirming that psoriatic skin expressed higher No relationships were found in patients or controls, either at the systemic or the local level, between ET-1 concentrations levels of specific mRNA for ET-1. and: age, sex, smoking history, and physical activity (data not shown).
IL-8 in skin extracts

IL-8 determinations are reported only for skin extracts, due ET-1 mRNA in skin extracts
to the fact that serum levels were mainly under detection limits. The skin extract data (Fig. 2) confirmed that IL-8 is To verify and confirm results obtained by ET-1 ELISA from skin extracts, mRNA from small biopsies was extracted and increased in lesional psoriatic skin (median 8.1 pg/mg TP; minimum 3.5 pg/mg tp; maximum 26.2 pg/mg TP) as compared specific messengers for ET-1 were reversely transcribed and amplified by RT-PCR. A single DNA fragment of the expected to non-lesional (median 5 pg/mg TP; minimum 1.9 pg/mg TP; maximum 7.1 pg/mg TP; p=0.02) and normal skin (median size (462 bp) was amplified in the skin samples. Fig. 3A shows the amplification signal of ET-1 mRNA from 2 psoriatic 4.5 pg/mg TP, minimum 0.8 pg/mg TP; maximum 5.9 pg/mg TP: p=0.04). This is in agreement with previous findings patients and one healthy volunteer. The specificity of this band was confirmed by southern blot analysis with a 32P-labelled published in the literature (13, 15) . Interestingly, at the lesional level, we could observe a internal probe (data not shown).
The densitometric analysis of the bands showed an increased significant correlation between ET-1 and IL-8 levels (r=0.76, p= 0.05) (Fig. 4) . As expected, the above-mentioned results expression of mRNA for ET-1 in lesional skin samples of psoriatic patients, compared with non lesional and with normal showed that IL-8 amounts were significantly correlated with the PASI scores (r=0.78, p=0.04). skin (Fig. 3B) .
behaviour paralleled that of IL-8. In fact, skin extract IL-8 was increased in the lesional skin and was significantly correlated to the PASI scores. No significant difference was found between normal and non-lesional skin. Finally, in accord with a possible ET-1 induction by IL-8, or alternatively a common induction by TNF-alpha (24), a significant correlation was observed between ET-1 and IL-8 amounts, at the lesional level.
Although this type of investigation does not provide information concerning the cellular source of this molecule, on the basis of the previous data, it is supposable that ET-1 mainly originates from endothelial cells, keratinocytes and mastcells.
Some speculations could be raised concerning the significance of the high ET-1 concentrations observed in involved areas of psoriatic skin.
In vitro studies clearly indicate that IL-8 induces ET-1 synthesis and that both act as mitogenic factors for the keratinocyte (6, 14, 24) . In particular, the inhibition of the antagonist for the ET receptors demonstrates that ET-1 is one of the most important factors involved in keratinocyte proliferation, which, in turn, could lead to abnormal proliferation DISCUSSION and turnover of keratinocytes in psoriasis (6) .
Since ET-1 is also mitogenic for endothelial and vascular Previous reports have revealed a significant increase in ET-1 and ET-2 plasma levels in psoriatic patients, in comparison smooth muscle cells (25) , it could participate in the angiogenetic processes (26), reported to be one of the earliest with the controls (19, 20) .
Our study, showing increased serum ET-1 concentrations in changes seen in the psoriatic lesion (27) , probably driven by IL-8 and other cytokines, in the context of a more complex psoriatic patients, also found a direct correlation between serum ET-1 levels and PASI scores, suggesting that ET-1 is network.
A controversial point might be the discrepancy between the linked to the PASI score, principally representing an index of the disease extension. Therefore, it is possible that serum ETstrong vasoconstrictive property of ET-1 and the marked dilation of the papillary microvessels characteristic of psoriatic 1 measurements can be useful in monitoring psoriasis.
To evaluate the possibility that the increased serum ET-1 lesions and possibly due to the increased amounts of inducible nitric oxide synthase, recently reported (28) . ET-1 increase concentrations could depend on lesional skin amounts, the present paper analyzed the ET-1 levels of lesional, non-lesional may also be the result of endothelial cell activation (with subsequent ET-1 synthesis and release) and it is possible that and normal skin. To standardize possible differences due to the biopsy variations, the data were expressed as pg/TP.
ET-1, reflecting the activation of inflammatory processes, only represents the biological response directed to control At the local level, we found that skin extracts of lesional psoriatic skin contained higher ET-1 concentrations as comvasodilation. Interestingly, the mitogenic activity of this molecule both pared to non-lesional and normal skin, indicating that the highest levels of ET-1 were associated with the psoriatic on keratinocyte and endothelium, together with its neoangiogenic properties, may contribute to maintain the psoriatic plaque. The uninvolved skin did not show significant differences in comparison with the skin of normal individuals, manifestations. Finally, IL-8 and ET-1 molecules contribute to the leukocyte although an evident correlation could be observed between ET-1 amounts measured in lesional and non-lesional skin of influx described in the lesional skin, due to their potent chemoattractant activities (8) . the same patients, suggesting a possible participation of the whole skin in the disease (21) (22) (23) .
Although our findings are suggestive of a role of ET-1 in the psoriatic cytokine network, further investigations are in The data obtained at the protein level were confirmed at the mRNA level by RT-PCR analysis, performed in skin progress to better clarify its activity in the inflammatory phenomena associated with this dermatosis. extracts. Thus, the same increasing concentration gradient of ET-1 is evident for normal, non-lesional and lesional skin.
As observed for serum ET-1 levels, skin extract ET-1
